Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2022-04-06 AGM Information
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PHARMANUTRA - CS - Pubblicazione lista e documenti per assemblea
AGM Information Classification · 1% confidence The document is an official regulatory announcement (Informazione Regolamentata) from PHARMANUTRA S.P.A. The subject line explicitly states: 'CS - Pubblicazione lista e documenti per assemblea' (Publication of list and documents for the meeting). The body confirms the publication of proposals and lists for the upcoming Ordinary Shareholders' Meeting (Assemblea Ordinaria) scheduled for April 27, 2022, specifically mentioning the list for the nomination of the Board of Statutory Auditors (Collegio Sindacale). This document is not the full AGM presentation (AGM-R), nor is it the proxy solicitation material itself (PSI), but rather the announcement that the necessary documentation related to the meeting agenda items (like board nominations) has been made available to the public. Since it announces the publication of materials for a shareholder meeting, it strongly aligns with the purpose of a Report Publication Announcement (RPA) or, given the context of shareholder meetings and related documents, potentially a Regulatory Filing (RNS) if RPA is too general. However, the core action described is the 'PUBBLICAZIONE DELLA DOCUMENTAZIONE PER L'ASSEMBLEA'. Given the options, RPA (Report Publication Announcement) fits best as it announces the availability of documents for a corporate event, although the content is highly specific to shareholder meeting materials. If the document were the actual proxy statement or the AGM presentation, other codes would apply. Since it's an announcement about the availability of documents for the AGM, RPA is the most precise fit among the choices that describe an announcement rather than the final report.
2022-04-06 Italian
Deposito della lista per la nomina del Collegio Sindacale - Presentation of list for the appointment of the Board of Statutory Auditors
AGM Information Classification · 1% confidence The document is a formal announcement from PHARMANUTRA S.P.A. regarding the filing of a list of candidates for the appointment of the Board of Statutory Auditors (Collegio Sindacale) for an upcoming Shareholders' Meeting. It specifically mentions the reopening of the term for minority shareholders to submit additional lists, citing Italian regulatory articles (Art. 144-octies, Art. 144-sexies of CONSOB Regulation). This type of announcement concerns corporate governance, shareholder meetings, and the composition of oversight bodies. While it relates to the AGM, the core subject is the formal process of nominating the auditors, which falls under governance/board-related announcements. Since the document is an official notice about the process leading up to a shareholder vote/meeting concerning board composition (Statutory Auditors), it aligns best with Board/Management Information (MANG) or Governance Information (CGR). Given the focus on the formal submission process and regulatory compliance for auditor nomination, CGR (Governance Information) is a strong fit, as is MANG (Board/Management Information). However, the specific focus on the 'Collegio Sindacale' (Statutory Auditors) nomination process, which is a key governance function, makes CGR the most precise fit among the provided options, as MANG usually refers to changes in executive management or the main Board of Directors. It is not a proxy statement (PSI) or AGM material itself, but a regulatory notice about the nomination process.
2022-04-03 Italian
Report on Corporate Governance and Ownership structure
Governance Information Classification · 1% confidence The document is explicitly titled "REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A." for the Financial Year 2021, prepared in accordance with article 123bis of Italian Legislative Decree no. 58/1998 (TUF). The table of contents details sections covering ownership structure, Board of Directors, Committees, Internal Control, and Statutory Auditors, which are core components of a Corporate Governance Report. The glossary also defines 'Report' as 'this report on corporate governance and ownership structures that companies are required to prepare pursuant to art. 123-bis, TUF.' This directly aligns with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, often mandated by specific articles like 123-bis.
2022-03-31 English
Financial Report 2021
Annual Report Classification · 1% confidence The document is titled 'ANNUAL FINANCIAL REPORT' for PharmaNutra S.p.A. for the period ending 31 December 2021. It contains comprehensive financial statements, management reports, explanatory notes, and an independent auditor's report. This aligns with the definition of an Annual Report (10-K equivalent for international entities). FY 2021
2022-03-31 English
PR - PHARMANUTRA - Notice publication and avaiability Annual Financial Report and Report CG
Report Publication Announcement Classification · 1% confidence The document is a regulatory announcement dated March 31, 2022, from PHARMANUTRA S.P.A. The subject line explicitly states: 'PR - PHARMANUTRA - Notice publication and avaiability Annual Financial Report and Report CG'. The body confirms that the 'Annual Financial Report as at 31 December 2021' and the 'Report on corporate governance and ownership structures' are now available to the public. Since the document's primary function is to announce the publication and availability of other reports (the Annual Financial Report and the Corporate Governance Report), and given its relatively short length (4944 characters), it fits the definition of a Report Publication Announcement (RPA). It is not the Annual Financial Report (10-K) itself, but the notice about it.
2022-03-31 English
Relazione sul Governo Societario e gli assetti proprietari
Governance Information Classification · 1% confidence The document title is "RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI DI PHARMANUTRA S.P.A. ESERCIZIO 2021" (Report on Corporate Governance and Ownership Structure of Pharmanutra S.p.A. Fiscal Year 2021). It explicitly states it is prepared pursuant to art. 123-bis of D. Lgs. 58/1998 (the Italian Consolidated Financial Act, or TUF, as referenced in the glossary). Article 123-bis mandates the Corporate Governance Report. The detailed index confirms the content covers ownership structure, board composition, internal committees, risk management, and remuneration, which are all standard components of a Corporate Governance Report in the Italian regulatory framework. This aligns perfectly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, often mandated by specific articles like 123-bis.
2022-03-31 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.